239 related articles for article (PubMed ID: 37709921)
1. Pharmacokinetics and pharmacodynamics of Rh2 and aPPD ginsenosides in prostate cancer: a drug interaction perspective.
Ben-Eltriki M; Shankar G; Tomlinson Guns ES; Deb S
Cancer Chemother Pharmacol; 2023 Dec; 92(6):419-437. PubMed ID: 37709921
[TBL] [Abstract][Full Text] [Related]
2. Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
Musende AG; Eberding A; Jia W; Ramsay E; Bally MB; Guns ET
Prostate; 2010 Sep; 70(13):1437-47. PubMed ID: 20687217
[TBL] [Abstract][Full Text] [Related]
3. A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer.
Musende AG; Eberding A; Wood CA; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Tomlinson Guns ES
Anticancer Drugs; 2012 Jun; 23(5):543-52. PubMed ID: 22481061
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells.
Ben-Eltriki M; Deb S; Adomat H; Tomlinson Guns ES
J Steroid Biochem Mol Biol; 2016 Apr; 158():207-219. PubMed ID: 26709138
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction of calcitriol with 20(S)-protopanaxadiol in mice: Determined by LC/MS analysis.
Ben-Eltriki M; Hassona M; Meckling G; Adomat H; Deb S; Tomlinson Guns ES
Eur J Pharm Sci; 2019 Mar; 130():173-180. PubMed ID: 30654110
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
7. Anticancer property of ginsenoside Rh2 from ginseng.
Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
[TBL] [Abstract][Full Text] [Related]
8. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.
Liu J; Shimizu K; Yu H; Zhang C; Jin F; Kondo R
Fitoterapia; 2010 Oct; 81(7):902-5. PubMed ID: 20554003
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 May; 141():94-103. PubMed ID: 24486455
[TBL] [Abstract][Full Text] [Related]
10. Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol.
Chiu NT; Tomlinson Guns ES; Adomat H; Jia W; Deb S
Biopharm Drug Dispos; 2014 Mar; 35(2):104-18. PubMed ID: 24151189
[TBL] [Abstract][Full Text] [Related]
11. 1α,25-Dihydroxyvitamin D
Ben-Eltriki M; Deb S; Guns EST
J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
[TBL] [Abstract][Full Text] [Related]
12. (20S)-Protopanaxadiol Ginsenosides Induced Cytotoxicity via Blockade of Autophagic Flux in HGC-27 Cells.
Han Q; Han L; Tie F; Wang Z; Ma C; Li J; Wang H; Li G
Chem Biodivers; 2020 Jul; 17(7):e2000187. PubMed ID: 32384197
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells.
Popovich DG; Kitts DD
J Biochem Mol Toxicol; 2004; 18(3):143-9. PubMed ID: 15252870
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future.
Guan W; Qi W
Phytomedicine; 2023 Sep; 118():154938. PubMed ID: 37406390
[TBL] [Abstract][Full Text] [Related]
15. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells.
Zhao Y; Bu L; Yan H; Jia W
Planta Med; 2009 Aug; 75(10):1124-8. PubMed ID: 19291609
[TBL] [Abstract][Full Text] [Related]
16. Potential of ginsenoside Rh
Li K; Li Z; Men L; Li W; Gong X
Chin J Nat Med; 2022 Dec; 20(12):881-901. PubMed ID: 36549803
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
Yu Y; Zhou Q; Hang Y; Bu X; Jia W
Cancer; 2007 Jun; 109(11):2374-82. PubMed ID: 17464948
[TBL] [Abstract][Full Text] [Related]
19. Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: An updated review.
Xu W; Lyu W; Duan C; Ma F; Li X; Li D
Fitoterapia; 2023 Jun; 167():105514. PubMed ID: 37084851
[TBL] [Abstract][Full Text] [Related]
20. Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
Musende AG; Eberding A; Wood C; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Guns ET
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1085-95. PubMed ID: 19301006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
